AU Patent

AU2013254940A1 — Auris formulations for treating otic diseases and conditions

Assigned to Otonomy Inc · Expires 2014-01-16 · 12y expired

What this patent protects

Auris Formulations For Treating Otic Diseases And Conditions Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered lo…

USPTO Abstract

Auris Formulations For Treating Otic Diseases And Conditions Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures. AH%(RAMMR9~4 1 i3-HTG

Drugs covered by this patent

Patent Metadata

Patent number
AU2013254940A1
Jurisdiction
AU
Classification
—
Expires
2014-01-16
Drug substance claim
No
Drug product claim
No
Assignee
Otonomy Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.